Subscribe
farmer-3
fotografixx / iStockphoto.com
22 March 2018Big Pharma

European Commission clears Bayer’s $62.5bn Monsanto buy

The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Scientist admits to Monsanto trade secret espionage
10 January 2022   A former Monsanto employee has pled guilty to conspiring to steal trade secrets from the biotech company in order to share the information with the Chinese government.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.
Europe
European Commission approves BASF deal to acquire Bayer assets
2 May 2018   The European Commission has approved agrochemical company BASF’s acquisition of some of Bayer’s crop science business after BASF vowed to sell certain assets.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Scientist admits to Monsanto trade secret espionage
10 January 2022   A former Monsanto employee has pled guilty to conspiring to steal trade secrets from the biotech company in order to share the information with the Chinese government.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.
Europe
European Commission approves BASF deal to acquire Bayer assets
2 May 2018   The European Commission has approved agrochemical company BASF’s acquisition of some of Bayer’s crop science business after BASF vowed to sell certain assets.

More on this story

Americas
Scientist admits to Monsanto trade secret espionage
10 January 2022   A former Monsanto employee has pled guilty to conspiring to steal trade secrets from the biotech company in order to share the information with the Chinese government.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.
Europe
European Commission approves BASF deal to acquire Bayer assets
2 May 2018   The European Commission has approved agrochemical company BASF’s acquisition of some of Bayer’s crop science business after BASF vowed to sell certain assets.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB